Legislative Research: WI SB1032 | 2025-2026 | Regular Session
Other Sessions
| Session | Title/Description | Last Action |
|---|---|---|
| 2025-2026 Regular Session (Failed) | An Act to create 77.51 (9rm) and 77.54 (14) (g) of the statutes; Relating to: a sales and use tax exemption for the sale of over-the-counter drugs. (FE) [SB1032 2025 Detail][SB1032 2025 Text][SB1032 2025 Comments] | 2026-03-23 Failed to pass pursuant to Senate Joint Resolution 1 |
| 2023-2024 Regular Session (Failed) | An Act to create 146.901 of the statutes; Relating to: prescription drug cost reporting by manufacturers and providing a penalty. [SB1032 2023 Detail][SB1032 2023 Text][SB1032 2023 Comments] | 2024-04-15 Failed to pass pursuant to Senate Joint Resolution 1 |
| 2021-2022 Regular Session (Failed) | An Act Relating to: methamphetamine addiction treatment grants. (FE) [SB1032 2021 Detail][SB1032 2021 Text][SB1032 2021 Comments] | 2022-03-15 Failed to pass pursuant to Senate Joint Resolution 1 |
References Online
Legislative Citation
APA
WI SB1032 | 2025-2026 | Regular Session. (2026, March 23). LegiScan. Retrieved October 26, 2026, from https://legiscan.com/WI/bill/SB1032/2025
MLA
"WI SB1032 | 2025-2026 | Regular Session." LegiScan. LegiScan LLC, 23 Mar. 2026. Web. 26 Oct. 2026. <https://legiscan.com/WI/bill/SB1032/2025>.
Chicago
"WI SB1032 | 2025-2026 | Regular Session." March 23, 2026 LegiScan. Accessed October 26, 2026. https://legiscan.com/WI/bill/SB1032/2025.
Turabian
LegiScan. WI SB1032 | 2025-2026 | Regular Session. 23 March 2026. https://legiscan.com/WI/bill/SB1032/2025 (accessed October 26, 2026).
Same As/Similar To
| Bill | Relationship | Date | Title | Last Action |
|---|---|---|---|---|
| AB1100 | Crossfiled | 2026-03-25 | A sales and use tax exemption for the sale of over-the-counter drugs. (FE) | Fiscal estimate received |
